![Starting and target doses of common ACE inhibitors used in clinical... | Download Scientific Diagram Starting and target doses of common ACE inhibitors used in clinical... | Download Scientific Diagram](https://www.researchgate.net/publication/272444455/figure/tbl1/AS:968596473774081@1607942803170/Starting-and-target-doses-of-common-ACE-inhibitors-used-in-clinical-practice-for-heart.png)
Starting and target doses of common ACE inhibitors used in clinical... | Download Scientific Diagram
![JCM | Free Full-Text | An Up-to-Date Article Regarding Particularities of Drug Treatment in Patients with Chronic Heart Failure JCM | Free Full-Text | An Up-to-Date Article Regarding Particularities of Drug Treatment in Patients with Chronic Heart Failure](https://www.mdpi.com/jcm/jcm-11-02020/article_deploy/html/images/jcm-11-02020-g001.png)
JCM | Free Full-Text | An Up-to-Date Article Regarding Particularities of Drug Treatment in Patients with Chronic Heart Failure
![Molecules | Free Full-Text | Is It Still Relevant to Discover New ACE Inhibitors from Natural Products? YES, but Only with Comprehensive Approaches to Address the Patients’ Real Problems: Chronic Dry Cough Molecules | Free Full-Text | Is It Still Relevant to Discover New ACE Inhibitors from Natural Products? YES, but Only with Comprehensive Approaches to Address the Patients’ Real Problems: Chronic Dry Cough](https://pub.mdpi-res.com/molecules/molecules-28-04532/article_deploy/html/images/molecules-28-04532-g001-550.jpg?1685719723)
Molecules | Free Full-Text | Is It Still Relevant to Discover New ACE Inhibitors from Natural Products? YES, but Only with Comprehensive Approaches to Address the Patients’ Real Problems: Chronic Dry Cough
![Beta-blocker/ACE inhibitor therapy differentially impacts the steady state signaling landscape of failing and non-failing hearts | Scientific Reports Beta-blocker/ACE inhibitor therapy differentially impacts the steady state signaling landscape of failing and non-failing hearts | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-08534-0/MediaObjects/41598_2022_8534_Fig1_HTML.png)
Beta-blocker/ACE inhibitor therapy differentially impacts the steady state signaling landscape of failing and non-failing hearts | Scientific Reports
![Cureus | A Review of the Mechanism of Action of Drugs Used in Congestive Heart Failure in Pediatrics | Article Cureus | A Review of the Mechanism of Action of Drugs Used in Congestive Heart Failure in Pediatrics | Article](https://assets.cureus.com/uploads/figure/file/474685/article_river_7efd6dd0486811eda0a2697ccdeda003-IMG_20221009_224530_450.png)
Cureus | A Review of the Mechanism of Action of Drugs Used in Congestive Heart Failure in Pediatrics | Article
![Which Inhibitor of the Renin–Angiotensin System Should Be Used in Chronic Heart Failure and Acute Myocardial Infarction? | Circulation Which Inhibitor of the Renin–Angiotensin System Should Be Used in Chronic Heart Failure and Acute Myocardial Infarction? | Circulation](https://www.ahajournals.org/cms/asset/b09cd381-a0fe-4f89-a609-30556cbeeb07/21ff1.jpeg)
Which Inhibitor of the Renin–Angiotensin System Should Be Used in Chronic Heart Failure and Acute Myocardial Infarction? | Circulation
ACE Inhibitors: Drug List, Side Effects, Mechanism of Action, Example Medications, Contraindications — EZmed
![Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction | Clinical Research in Cardiology Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction | Clinical Research in Cardiology](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00392-020-01598-w/MediaObjects/392_2020_1598_Figa_HTML.png)
Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction | Clinical Research in Cardiology
![Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients - The Lancet Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients - The Lancet](https://www.thelancet.com/cms/attachment/201f4b3d-5b6f-4542-bc19-8bbe582e6e55/gr1.gif)
Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients - The Lancet
![From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5) | Journal of the American College of Cardiology From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5) | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/8f66d894-9c8b-4af7-9b5d-5f1b51e5777b/fx1.jpg)
From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5) | Journal of the American College of Cardiology
Meta-Analysis of Combined Therapy with Angiotensin Receptor Antagonists versus ACE Inhibitors Alone in Patients with Heart Failure | PLOS ONE
![Abstract 16432: Optimal Dosing of ACE Inhibitors and ARBs in Chronic Heart Failure Patients - A Meta-analysis of Randomized Controlled Trials | Circulation Abstract 16432: Optimal Dosing of ACE Inhibitors and ARBs in Chronic Heart Failure Patients - A Meta-analysis of Randomized Controlled Trials | Circulation](https://www.ahajournals.org/cms/asset/f60a9987-0c47-487a-a3c5-d8f9ef3f0cc2/g16432.jpeg)